ライフサイエンスコーパス: referral center

1 ferred to Oslo University Hospital (tertiary referral center).

2 h MRI metrics was conducted at a tertiary MS referral center.

3 primary open angle glaucoma in our tertiary referral center.

4 ween 2013 and 2015 at a single tertiary care referral center.

5 , 2014, to October 31, 2015, at a university referral center.

6 with 35 dexamethasone implants at a tertiary referral center.

7 er 1, 2011, to April 18, 2016 at an academic referral center.

8 t an urban, academic ED at a quaternary care referral center.

9 ervational cohort study at a single national referral center.

10 and 2017 in a cohort of PLWH in a Dutch HIV referral center.

11 5) for vascular anomalies at a tertiary care referral center.

12 June to November 2015 at a tertiary clinical referral center.

13 to December 1, 2014, at a tertiary academic referral center.

14 8, 2006, until June 17, 2015, at a tertiary referral center.

15 ction of autoantibodies in a neuroimmunology referral center.

16 nce tomography, at a tertiary ophthalmologic referral center.

17 id nodules in pediatric patients in a single referral center.

18 Setting: Single-center study at an academic referral center.

19 ge academic inner-city trauma and quaternary referral center.

20 al Sloan-Kettering Cancer Center, a tertiary referral center.

21 th MRE in pregnant CD patients in a tertiary referral center.

22 pril 2019 at a single tertiary ophthalmology referral center.

23 th follow-up of 5 to 25 months at a tertiary referral center.

24 adiation of normal human skin at an academic referral center.

25 utpatients routinely followed up at a single referral center.

26 arge cohort of celiacs diagnosed in a single referral center.

27 010, through October 31, 2012, at a tertiary referral center.

28 arative analysis was conducted at a tertiary referral center.

29 t subsequent surgical repair at a university referral center.

30 ter syndrome (RS) over a 10-year period at a referral center.

31 March 31, 2013, in a tertiary hepatobiliary referral center.

32 evaluated by a single surgeon at a tertiary referral center.

33 a new technique was conducted at a tertiary referral center.

34 6 and October 2018 at a single ophthalmology referral center.

35 spective medical record review at a tertiary referral center.

36 , 52 years; range, 9-79 years) in a tertiary referral center.

37 rol participants at a tertiary ophthalmology referral center.

38 2002, and December 31, 2012, at an academic referral center.

39 onal case series was conducted at a tertiary referral center.

40 ry of microbial keratitis seen at a tertiary referral center.

41 tive case series was conducted at a tertiary referral center.

42 hildren with cataract operated at a tertiary referral center.

43 hort study was conducted in a Dutch tertiary referral center.

44 T, were identified at a single tertiary-care referral center.

45 sis, confirmed by histology, from a tertiary referral center.

46 ere prospectively recruited at an outpatient referral center.

47 rtrophic cardiomyopathy cohort at a tertiary referral center.

48 ctive cohort included diagnosed with MC at a referral center.

49 of patients followed up at our tertiary IBD referral Center.

50 nts followed <=17 years in a single national referral center.

51 trospective review from a tertiary pediatric referral center.

52 eyes) with ARN treated in a single tertiary referral center.

53 with unexplained heart failure at a tertiary referral center.

54 Single-center, tertiary eye care referral center.

55 ectional study at a single academic tertiary referral center.

56 0 to December 31, 2012 at a large university referral center.

57 2011, through April 22, 2016, at an academic referral center.

58 ic phenotypes at a university-based tertiary referral center.

59 ed for at Vanderbilt University, an academic referral center.

60 ist Photobiology Unit of a tertiary academic referral center.

61 cranial and spinal operations in a tertiary referral center.

62 oxygenation from 2012 to 2018 at a tertiary referral center.

63 e, retrospective case series at a University Referral Center.

64 lity treatments in a national retinoblastoma referral center.

65 ase series at a single institution, tertiary referral center.

66 The study was performed in a tertiary referral center.

67 imated incidence of 0.0025 to 0.014 in large referral centers.

68 omes of PRRT in esthesioneuroblastoma from 2 referral centers.

69 graphic diagnosis of LVNC underwent CMR at 5 referral centers.

70 entified from a pool of patients at 2 retina referral centers.

71 m hepatitis B virus DNA in European tertiary referral centers.

72 HCM without prior SCD event, from 2 tertiary referral centers.

73 ts (1329 eyes) were enrolled from 3 academic referral centers.

74 y 2015, in neurology departments at tertiary referral centers.

75 , MSH6, and PMS2) using databases from 13 US referral centers.

76 d 76,817 patients were hospitalized at three referral centers.

77 iatric PAH patients differed between 3 major referral centers.

78 unselected CD children diagnosed by national referral centers.

79 l multicenter cohort study among MS tertiary referral centers.

80 ith RFA from 2003 through 2011 at 3 tertiary referral centers.

81 were retrospectively analyzed at 2 tertiary referral centers.

82 9 patients (11 eyes) with AMN at 6 tertiary referral centers.

83 multicenter study conducted at 39 outpatient referral centers.

84 identified from 2 databases from 2 tertiary referral centers.

85 d in prospective OAT databases at 2 tertiary referral centers.

86 quiescent CNV were analyzed in 2 high-volume referral centers.

87 In our tertiary care referral center, 164 subjects with preinvasive lesions w

88 = 486) having curative surgery at a tertiary referral center (2002-2011) was conducted.

89 Even in the setting of a tertiary care referral center, 21.6% of these readmissions were to non

90 try of patients with BAV treated at tertiary referral centers, 2118 patients with BAV were evaluated.

91 At 3 tertiary referral centers, 228 patients with non-ischemic cardiom

92 ve cohort study performed at a tertiary care referral center, 50 African American patients 60 years o

93 f 500 eyes that underwent DMEK at a tertiary referral center, 7 eyes developed typical clinical signs

94 al transfers from less resourced ICUs to the referral center, a trend that is not readily explained b

95 efore, strict dermatologic surveillance in a referral center aided by digital follow-up is mandatory,

96 Interventional case series at a tertiary referral center among 16 patients.

97 the DCTN1 gene in familial forms of PSP at a referral center among 21 patients with familial PSP-like

98 2012, to December 30, 2014, at a private MS referral center among 50 obese patients with MS who also

99 ve cohort study at an academic ophthalmology referral center among 507 patients with uveal melanoma w

100 hological case series at a tertiary eye care referral center among patients who underwent Boston type

101 and December 31, 2013, at tertiary academic referral centers among 9 patients (age range, 13-47 year

102 sessments was performed at an urban tertiary referral center and a regional center from January 1, 20

103 In vivo PET at tertiary neuroscience referral center and ex vivo immunocytochemistry of autop

104 r 2009 and November 2011 at an institutional referral center and reading center of patients with trea

105 Patients were recruited from referral centers and general neurology clinics in public

106 A combination of 17 tertiary referral centers and private practices worldwide contrib

107 y at the Radboudumc (tertiary ophthalmologic referral center) and the European Genetic Database for p

108 Massachusetts General Hospital (tertiary referral center) and two affiliated community hospitals.

109 general community clinics, primary care and referral centers, and ambulatory and hospitalized care.

110 at receives data from teaching hospitals and referral centers, as well as several pneumology, dermato

111 007, and December 31, 2013, at a dermatology referral center at a single institution.

112 ted population of Western New York HIV/AIDS, Referral Center at Erie County Medical Center (ECMC), 14

113 or Fuchs endothelial dystrophy at a tertiary referral center, best spectacle-corrected visual acuity

114 PWID aged >=18 years admitted to a tertiary referral center between 01/2016 and 07/2019, who receive

115 ciency virus [HIV] status) seen in a uveitis referral center between 1984 and 2014 were reviewed.

116 s of 63 patients who presented to a tertiary referral center between 2006 and 2015 with culture-posit

117 crobiota transplantation (FMT) at a tertiary referral center between 2011 and 2014 to determine risk

118 ive data on 682,704 patients from a tertiary referral center between 2011 and 2015, and identified hy

119 Newcastle mitochondrial disease specialized referral center between January 1, 2000, and January 31,

120 underwent pancreatectomy at a tertiary care referral center between January 1, 2005, and December 2,

121 going abdominal surgery for CD at a tertiary referral center between January 1998 and June 2014 were

122 nts undergoing genetic testing at a tertiary referral center between July 2005 and November 2010.

123 ancer patients who presented to our tertiary referral center between March 2011 and February 2015.

124 <21 years) who were evaluated at a tertiary referral center between November 1, 1975, and July 1, 20

125 al clinic appointment in a tertiary eye care referral center between November 2016 and July 2018 were

126 y ill burn patients admitted to our tertiary referral center between October 2013 and February 2016 w

127 ive pediatric PAH patients who visited the 3 referral centers between 2000 and 2010 were included.

128 ullary adenocarcinoma in 9 European tertiary referral centers between February 2006 and December 2017

129 lind clinical trial in 3 Australian tertiary referral centers between June 2013 and June 2016, with 1

130 1 consecutive patients enrolled at 3 Italian referral centers between June and November 2014 (end of

131 At 2 referral centers between October 1, 1995, and May 31, 20

132 ent-Methylphenidate, or ePOD-MPH) among ADHD referral centers between October 13, 2011, and June 15,

133 We conducted a 10-year cohort study in a referral center by collecting all pregnant women who dia

134 Databases from 2 referral centers comprising 2100 HCM patients were inter

135 tudy included patients from 25 ophthalmology referral centers diagnosed with TB uveitis and treated w

136 In two tertiary referral centers, donors undergoing left-sided nephrecto

137 eyes) who were treated at a single tertiary referral center during a 10-year period.

138 ohort study at an academic hospital tertiary referral center evaluating the growth rate of hepatic he

139 All patients seen at a dedicated tertiary referral center for a suspicion of vascular Ehlers-Danlo

140 all patients followed at the French National Referral Center for acute Q fever were included in a coh

141 onducted between 2011 and 2014 at a tertiary referral center for ALS.

142 and March 2015 at a tertiary dermatological referral center for anal cancer screening.

143 was conducted using records from a tertiary referral center for autoimmune bullous disorders.

144 hotodamaged skin was conducted in a tertiary referral center for dermatology between January 1, 2009,

145 At a tertiary care referral center for diabetic eye disease, a retrospectiv

146 ries of 76 patients presenting to a tertiary referral center for evaluation of chronic progressive ce

147 ed up with a family presenting to a tertiary referral center for evaluation of HSP for a decade until

148 the clinical database of a large quaternary referral center for genomic medicine in the Northwest of

149 des Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious

150 etween March 2002 and May 2015 in a tertiary referral center for multiple sclerosis, in collaboration

151 etrospective case series in an institutional referral center for multiple sclerosis, including 30 pat

152 Academic tertiary referral center for neurodegenerative disorders in 17 as

153 nal cohort study was conducted at a tertiary referral center for neurological diseases in Rio de Jane

154 and/or eye abnormalities, from a US tertiary referral center for neurological diseases using multiple

155 ried the medical records of a large tertiary referral center for patients with a history of prior hea

156 1, 2012, to July 30, 2015, in an outpatient referral center for patients with neurodegenerative dise

157 trial with a 2-year follow-up at a tertiary referral center for pediatric obesity in the Netherlands

158 patients of the 2004 to 2014 French National Referral Center for Q fever database.

159 y 2007 and April 2014 at the French National Referral Center for Q fever.

160 enter, Nijmegen, the Netherlands, a tertiary referral center for retinal disorders.

161 collection and explorations made in a single referral center for sickle cell disease in 2016.

162 n a case-control study conducted at a French referral center for SLE and antiphospholipid syndrome, 2

163 pective cohort study conducted in a tertiary referral center for the diagnosis and follow-up of gastr

164 rban catchment area and serves as a tertiary referral center for the province of Ontario).

165 Eyes with uveitis seen at a single tertiary referral center for which ME was the principal cause of

166 ecutive LMNA mutation carriers followed at 5 referral centers for a median of 7 years from first clin

167 nd, randomized clinical trial conducted at 5 referral centers for catheter ablation of atrial fibrill

168 ategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to December 2016

169 ly during the COVID-19 emergency was sent to referral centers for hepato-bilio-pancreatic, colorectal

170 Referral centers for HPB disease have been used as a str

171 study, 2 groups of patients from 2 tertiary referral centers for melanoma (Sydney Melanoma Diagnosti

172 21 private and 2 institutional US ambulatory referral centers for MMS.

173 ined contemporary patient cohorts at 3 major referral centers for pediatric PAH (New York [NY], Denve

174 study was conducted (1992-2010) in tertiary referral centers for treatment of cutaneous melanoma.

175 Patients prospectively registered in two referral centers for vascular liver disorders were eligi

176 s requires adequate technology, available at referral centers, for amyloid typing.

177 enous fungal endophthalmitis at a university referral center from 1990 to 2010 were reviewed.

178 than 10 years with ROP seen at our tertiary referral center from 2000 through 2018, 5 (3.6%) demonst

179 d database of VGAM cases managed at a single referral center from 2000 to 2014.

180 prospective case series at an institutional referral center from December 1, 2011, through February

181 ents who presented to a single tertiary care referral center from December 24, 1987, to June 18, 2010

182 gical oncology) at an academic tertiary care referral center from January 1, 1978, to December 31, 20

183 ently undergoing patch testing at a tertiary referral center from January 1, 2012, through November 3

184 nt recipients was recruited from a Brazilian referral center from January 2005 to December 2009; all

185 eatic surgery at a university-based tertiary referral center from July 1, 2013, through June 30, 2015

186 ed uveitis patients attending a tertiary eye referral center from Madrid (Spain) between 1989 and 201

187 spective cross-sectional study at a tertiary referral center from March 1, 2012, to January 1, 2013,

188 oing curative RT at a single academic cancer referral center from October 1, 2003, to August 31, 2013

189 o received ipilimumab at 9 academic tertiary referral centers from January 1, 2012, through August 1,

190 Hershey Medical Center, an academic tertiary referral center, from May 1, 2011, through November 30,

191 , to December 31, 2012, at an FTD specialist referral center (FRONTIER).

192 rophic cardiomyopathy evaluated at 2 Italian referral centers >3 decades.

193 rred to and managed at a tertiary university referral center have benefited from advances in HF medic

194 ween October 1985 and May 2014 at a tertiary referral center hosting the Dutch Cutaneous Lymphoma Reg

195 med at a corneal and ocular surface diseases referral center in 2010.

196 a Creu i Sant Pau, an institutional practice referral center in Barcelona, Spain, between May 1, 2015

197 n and serial TST, between 1998 and 2004 at a referral center in Brazil.

198 ospital Foundation Trust [CUHFT], a tertiary referral center in Cambridge, England.

199 r trial was conducted in a neonatal tertiary referral center in Germany.

200 This is a case report from an academic referral center in Miami, Florida, of a woman in her 60s

201 e cohort study performed at an institutional referral center in New York.

202 the diagnostic criteria for NS in a tertiary referral center in Paris, France, from January 1, 1990,

203 onal study of neonatal admissions at a large referral center in sub-Saharan Africa to determine the p

204 ase and 445 matched controls from a tertiary referral center in the U.K.

205 t results from patients attending a tertiary referral center in the UK.

206 dy, 2 analyses were performed at an academic referral center in the upper Midwest.

207 010 through February 2013 at a tertiary care referral center in Utrecht, the Netherlands.

208 ts 6 years and older at baseline at tertiary referral centers in Europe, the United States, and the U

209 ence for severe acute chest syndrome in four referral centers in France.

210 ruited from 8 hospital-based thyroid-disease referral centers in Italy between 2006 and 2008.

211 venom as well as idiopathic anaphylaxis from referral centers in Italy, Slovenia, and the United Stat

212 s conducted on patients seen at two tertiary referral centers in Mexico.

213 Developing Brain-Methylphenidate) among ADHD referral centers in the greater Amsterdam area in the Ne

214 r older and had a visit for HS at 1 of the 2 referral centers in the past 2 years (from January 1, 20

215 l trends in cases were derived from national referral centers in the period 2004-2014.

216 e case series of 21 patients from 5 tertiary referral centers in the United Kingdom and Australia wit

217 doscopic examination for BE at tertiary care referral centers in the United States and Europe.

218 ctive cohort study was conducted at tertiary referral centers in the United States and Europe.

219 ectional survey study of 154 patients from 2 referral centers in the United States and in Denmark was

220 rimary data were accumulated from 6 tertiary referral centers in the United States, Belgium, United K

221 ered enrollment into the study at 5 academic referral centers in the United States; 13 declined parti

222 A retrospective case series in a tertiary referral center included 100 consecutive patients underg

223 onal cohort analysis performed at a tertiary referral center included 43 laser-naive patients with PD

224 ational study performed at 2 ocular oncology referral centers included 339 patients in a primary coho

225 hns Health Center, a tertiary-level melanoma referral center, included 1623 patients with melanoma di

226 ar randomized controlled trial at a tertiary referral center, including 263 adults (178 with CD and 8

227 Retrospective observational case series at a referral center involving 17 eyes of 17 patients.

228 typing with adequate technology available at referral centers, is mandatory to confirm AL amyloidosis

229 ults were similar to those of other tertiary referral centers, it would be reasonable to perform furt

230 om patients undergoing surgery at 4 tertiary referral centers (January 2010 through June 2017).

231 logists, and geneticists from retinoblastoma referral centers located in various geographic regions w

232 Italian tertiary referral center medical-surgical ICU.

233 At a large tertiary care referral center, midterm quality outcomes after robotic

234 um of Pulmonary Hypertension Identified at a Referral Center) MRI database.

235 gy department affiliated with the French NF1 referral center network.

236 Single-site, tertiary care referral center observational study of 1145 of 2197 cons

237 ve, noncomparative case series at a tertiary referral center (Ocular Oncology Service of Wills Eye Ho

238 etrospective analysis at a tertiary academic referral center of 100 consecutive patients undergoing p

239 Prospective case series in a referral center of 22 eyes from 18 patients (mean age, 7

240 etrospective analysis from a single tertiary referral center of all patients older than 18 years old

241 vember 2017 at a single large urban academic referral center of all patients self-referred to the eme

242 etrospective review at a university tertiary referral center of all pregnant patients seen with abdom

243 Cross-sectional study at a referral center of chronobiology among 12 young healthy

244 al study of 12 young healthy volunteers at a referral center of chronobiology.

245 8-80 years), diagnosed at the Celiac Disease Referral Center of our University Hospital (Bologna, Ita

246 ry translational analysis at a tertiary care referral center of patients with completely treated HER2

247 s-sectional study of CD in the Mediterranean referral centers offers a puzzling picture of the capaci

248 period 1998 to 2015 from the single national referral center on autoimmune bullous diseases.

249 Multicenter (8 endoscopic referral centers), open-label, parallel, randomized clin

250 keratoplasty recipients at a single tertiary referral center over 20 years.

251 5 autopsies examined at an academic tertiary referral center over 21 years were tabulated for histopa

252 Thirty-six French MS tertiary referral centers participated.

253 At a single tertiary referral center, patients with HCC were randomly assigne

254 ary 7, 2014, to July 15, 2015, in a tertiary referral center pediatric dermatology clinic and in 2 pr

255 Participants were enrolled from a single referral center recruiting nationwide in Norway.

256 ing and currently performed only in tertiary referral centers, represents the bottleneck in the work-

257 ty of Pennsylvania Health System, a tertiary referral center serving a population with a high proport

258 The database of a national referral center specialized in genetic sensory diseases

259 h additional wedge resections, at a tertiary referral center specialized in laparoscopic hepato-pancr

260 ters on the basis of results from a tertiary referral center specializing in complex filter retrieval

261 These data, from an ocular tertiary referral center, suggest that conjunctival tumors in chi

262 The study took place among eight U.S. referral centers that are part of the DILIN.

263 anada, teaching hospitals are mainly cardiac referral centers that are potentially well suited toward

264 erformed between 2004 and 2015 at 4 tertiary referral centers to identify pathologically confirmed PD

265 to compare results and value of care between referral centers, to perform health technology assessmen

266 lyzed at a tertiary academic ocular oncology referral center using a customized bioinformatic pipelin

267 e triage of high-risk patients to designated referral centers using a validated prehospital risk scor

268 and LLS for CRLMs in 9 European high-volume referral centers was performed.

269 In a single-blind study performed at 2 referral centers we assigned 148 patients with severe no

270 diatric patient visits presenting to a major referral center were analyzed to train and validate the

271 and 2018, patients with NSTI at a quaternary referral center were followed up for the outcomes of dea

272 fore uncomplicated triple DMEK at a tertiary referral center were included.

273 ng transvenous lead extraction at a tertiary referral center were prospectively gathered from 2004 to

274 spective study, patients in a hospital-based referral center were recruited from March 1, 2010, throu

275 adult patients treated in a single tertiary referral center were retrospectively identified and incl

276 Patients undergoing ERC at our tertiary referral center were retrospectively included.

277 rdiomyopathy from 2003 to 2019 at a tertiary referral center were reviewed retrospectively.

278 traumatic macular holes at a single tertiary referral center were reviewed.

279 1/1/2000 to 12/31/2009 at a single tertiary referral center were reviewed; clinical information was

280 between January 2011 and September 2016 in 3 referral centers were included.

281 Thirty-six patients with RRMS from referral centers were screened; 25 were enrolled.

282 mentia Cohort (longitudinal cohort, tertiary referral center) were studied.

283 ping surgical procedures at a large tertiary-referral center where overlapping surgery is performed.

284 -certified dermatologist at a large tertiary referral center, where ENFD testing became a routine par

285 -certified dermatologist at a large tertiary referral center, where ENFD testing became a routine par

286 neoplasia should be centralized in tertiary referral centers, where procedures are performed under o

287 of 263 patients at a large, urban, tertiary referral center who underwent either dynamic parathyroid

288 fants with unilateral congenital cataract in referral centers who were between ages 1 and 6 months at

289 Patients consecutively admitted to three referral centers who were receiving best supportive care

290 atients with esophageal cancer in a tertiary referral center, who underwent nCRT (5 weekly courses of

291 secutive patients with PXE from a university referral center whose diagnosis has been confirmed by ge

292 with active TB SLC seen at a single tertiary referral center with 6 months follow-up after initiation

293 the clinical experience of the authors in a referral center with a cohort of patients affected by ju

294 was evaluated in this complex scenario at a referral center with a multidisciplinary IE unit.

295 patients who were treated in a single 3(rd) referral center with bevacizumab using a loading dosage

296 a Hospital, a large, Canadian, tertiary care referral center with expertise in neurology and HSCT, fr

297 This study involved 5 tertiary referral centers with a specialized adult congenital hea

298 nfected necrosis, but should be performed at referral centers with the necessary endoscopic expertise

299 nosed with PEVAC were identified at 4 retina referral centers worldwide and underwent complete ophtha

300 osed with nePVAC were identified at 4 retina referral centers worldwide.